These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7011728)

  • 1. Studies on the biologic actions of biosynthetic human insulin in vitro and in diabetic man.
    Waldhäusl WK; Kastner G; Komjati M; Bratusch-Marrain P
    Diabetes Care; 1981; 4(2):205-8. PubMed ID: 7011728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.
    Olefsky JM
    Diabetes Care; 1981; 4(2):244-7. PubMed ID: 7011736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pancreatic human and biosynthetic human insulin with respect to their action on adipocytes and chick embryo fibroblasts.
    Zapf J; Froesch ER
    Diabetes Care; 1981; 4(2):257-9. PubMed ID: 7011741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin.
    Federlin K; Laube H; Velcovsky HG
    Diabetes Care; 1981; 4(2):170-4. PubMed ID: 7011720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic properties of biosynthetic human insulin in vitro.
    Beischer W; Maier V; Jonatha EM; Hartweg D; Kratzsch G
    Diabetes Care; 1981; 4(2):202-4. PubMed ID: 7011727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrimental effect of hyperosmolality on insulin-stimulated glucose metabolism in adipose and muscle tissue in vitro.
    Komjati M; Kastner G; Waldhäusl W; Bratusch-Marrain P
    Biochem Med Metab Biol; 1988 Jun; 39(3):312-8. PubMed ID: 3293636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biosynthetic human insulin and pork insulin in the Gerritzen test.
    Weinges K; Ehrhardt M; Enzmann F
    Diabetes Care; 1981; 4(2):180-2. PubMed ID: 7011722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic activity and pharmacokinetics of biosynthetic human insulin in the rat.
    Halban PA; Berger M; Gjinovci A; Renold AE
    Diabetes Care; 1981; 4(2):238-43. PubMed ID: 7011735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding and effect of biosynthetic human insulin on 2-deoxyglucose transport.
    Wieringa T; van Putten JP; Van Dijk-Besling M; Krans HM
    Diabetes Care; 1981; 4(2):254-6. PubMed ID: 7011740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency of biosynthetic human insulin determined in vitro.
    Fussgaenger RD; Ditschuneit HH; Martini H; Wiebauer-De Lenardis H; Etzrodt H; Thun C; Ditschuneit H; Pfeiffer EF; Enzmann F
    Diabetes Care; 1981; 4(2):228-34. PubMed ID: 7011733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of biosynthetic human insulin to human antibodies and receptors.
    Petersen KG; Schlüter K; Steinhilber S; Kerp L
    Diabetes Care; 1981; 4(2):248-9. PubMed ID: 7011737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system.
    Klier M; Kerner W; Torres AA; Pfeiffer EF
    Diabetes Care; 1981; 4(2):193-5. PubMed ID: 7011725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.
    Keefer LM; Piron MA; De Meyts P
    Diabetes Care; 1981; 4(2):209-14. PubMed ID: 7011729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biologic potency and binding affinity of biosynthetic human insulin in isolated rat adipocytes.
    Sonne O; Foley JE; Gliemann J
    Diabetes Care; 1981; 4(2):250-1. PubMed ID: 7011738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
    Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.
    Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P
    Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus.
    Gerich JE
    Diabetes Care; 1981; 4(2):262-4. PubMed ID: 7011743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas.
    Raptis S; Karaiskos C; Enzmann F; Hatzidakis D; Zoupas C; Souvatzoglou A; Diamantopoulos E; Moulopoulos S
    Diabetes Care; 1981; 4(2):155-62. PubMed ID: 7011717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative potencies of human and pork insulin during i.v. and oral glucose tolerance test in lean and obese persons.
    Nesher R; Sinai J; Litvin Y; Cerasi E
    Isr J Med Sci; 1985 Nov; 21(11):905-11. PubMed ID: 3908398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate-type allergy against insulin itself: clinical and immunologic studies on a diabetic patient with insulin intolerance.
    Schernthaner G; Ludwig H; Jarisch R; Bruneder H
    Diabetes Care; 1981; 4(2):196-201. PubMed ID: 7011726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.